Skip to main content

News

You are here

June 2025 Archive

UM Ventures, Baltimore Newsletter | Spring/Summer 2025

Have an invention?Disclose it to the UM Ventures, Baltimore team. Featured Article President’s Entrepreneurial Fellows Share Insights, Celebrate 10th Anniversary of the Program The fellows worked on five projects for Otter Immuno-Oncology, a seed-stage, preclinical biopharmaceutical company... read more

UMB Patent Awards | January - March 2025

Apparatus and Method for Septal PunchChinese patent issued January 7, 2025 UMB Inventors: James Gammie, MD (formerly UMSOM), Rachael Quinn, PhD (formerly UMSOM), Stephen Roller, MBA Small Molecule Inhibitors of GPCR GPR68 And Related Receptors For Treating Cancer, Glioblastoma, and Other... read more

In-House Experts: Tech Transfer Spotlight - Robert McCarthy, JD, PhD

Applying his scientific and legal expertise, Robert McCarthy, JD, PhD, supports University of Maryland, Baltimore’s (UMB) faculty inventors in securing and protecting intellectual property (IP) developed during their research. Since joining UMB in 2007, Dr. McCarthy has worked collaboratively with... read more

IP Rounds: Your Invention May Not Be Patentable and That’s Great

By Dustin Lee, Senior Patent Attorney for UMB Entrepreneurs and new inventors often see patents as the finish line of intellectual property (IP) protection. While patents offer significant advantages, an invention's non-patentability should not cause dismay. Generating commercial momentum is the... read more

Featured Partner: GlycoMantra

University of Maryland, Baltimore biotech startup, GlycoMantra, Inc., is redefining approaches to chronic and life-threatening diseases by translating complex glycobiological insights into transformative therapies. Founded by Hafiz Ahmed, PhD, president and chief executive officer, in 2014 and... read more

Featured Inventor: Ryan M. Pearson, PhD

Ryan M. Pearson, PhDAssociate Professor, Department of Pharmaceutical SciencesDirector of the Bio- and Nano-Technology CenterUniversity of Maryland School of Pharmacy Reprogramming dysregulated immune responses is a complex undertaking, but Ryan Pearson, PhD, associate professor of pharmaceutical... read more